Skip to main content

Month: February 2024

DIRTT Reports Fourth Quarter 2023 Financial Results

CALGARY, Alberta, Feb. 21, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”, “we”, “our”, “us” or “ours”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, today announced its financial results for the three and twelve months ended December 31, 2023. All financial information in this news release is presented in U.S. dollars, unless otherwise stated. Fourth Quarter 2023 HighlightsRevenue of $50.9 million, up 20% compared to the prior year period, representing the Company’s highest revenue quarter since 2019. Gross Profit improvement to $19.2 million or 37.8% of revenue in the fourth of 2023 from $11.6 million or 27.3% of revenue in the fourth quarter of 2022. Net income after tax and net income margin for the quarter of $1.0 million and 1.9%, respectively, compared to a...

Continue reading

Kneat Announces Record Revenue for Fourth Quarter and Full Year 2023

LIMERICK, Ireland, Feb. 21, 2024 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three- and twelve-month periods ended December 31, 2023. All dollar amounts are presented in Canadian dollars unless otherwise stated. Annual Recurring Revenue (ARR)1 at December 31, 2023, reaches $37.4 million, an increase of 55% year over year, and 19% from $31.4 million at September 30, 2023 Total revenue reaches $9.8 million in quarter four, an increase of 35% year over year SaaS revenue growth of 58% drives gross margin to 72% in quarter four Fourth-quarter gross profit grew 53% year over year to $7.0 million from $4.6 million “Kneat embarks on 2024 stronger than ever, after another...

Continue reading

Vital Energy Reports Fourth-Quarter and Full-Year 2023 Financial and Operating Results

Reports record total and oil production for 4Q-23 and FY-23 Plans to invest $750 – $850 million, increasing FY-24 oil production ~10% from 4Q-23 exit Updates development inventory to >10 years of oil-weighted locations TULSA, OK, Feb. 21, 2024 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) today reported fourth-quarter and full-year 2023 financial and operating results and provided its 2024 outlook. Supplemental slides have been posted to the Company’s website and can be found at www.vitalenergy.com. A conference call and webcast is planned for 7:30 a.m. CT, Thursday, February 22, 2024. Participation details can be found within this release. Fourth-Quarter 2023 HighlightsReported 4Q-23 net income of $281.4 million, Adjusted Net Income1 of $76.1 million...

Continue reading

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods Ended December 31, 2023 and 2022Net service revenue increased $8.8 million to $570.8 million compared to $562.0 million in 2022. Prior year included $15.9 million of net service revenue from our personal care business which was divested on March 31, 2023. Net income attributable to Amedisys, Inc. of $19.3 million, which is inclusive of $11.5 million in costs associated with with our merger transactions, compared to $31.7 million in 2022. Net income attributable to Amedisys, Inc. per diluted share of $0.59 compared to $0.97 in 2022.Adjusted Quarterly Results*Adjusted EBITDA of $56.7 million compared to $59.9 million in 2022. Adjusted...

Continue reading

Host Hotels & Resorts, Inc. Reports Results for 2023

Full Year Comparable Hotel RevPAR Growth of 8.1% Exceeded Midpoint of GuidanceReturned More Than $700 Million of Capital to Stockholders in 2023 and Announces $0.20 First Quarter DividendCompleted Multi-Year Transformational Reinvestment Programs and Development Projects BETHESDA, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust (“REIT”), today announced results for fourth quarter and full year 2023.OPERATING RESULTS(unaudited, in millions, except per share and hotel statistics)   Quarter ended December 31,       Year ended December 31,      2023   2022   Percent Change   2023   2022   Percent ChangeRevenues $ 1,323   $ 1,263   4.8 %   $ 5,311   $ 4,907   8.2 %Comparable hotel revenues⁽¹⁾   1,260     1,251   0.7 %     5,169     4,773   8.3 %Comparable...

Continue reading

Kaiser Aluminum Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter 2023 Highlights:Net Sales $722 Million; Conversion Revenue $361 Million Net Income $8 Million; Net Income per Diluted Share $0.47 Adjusted Net Income $10 Million; Adjusted Net Income per Diluted Share $0.60 Adjusted EBITDA $52 Million; Adjusted EBITDA Margin 14.3% Aerospace / High Strength Achieved Record Net Sales and Conversion RevenueFull Year 2023 Highlights:Net Sales $3.1 Billion; Conversion Revenue $1.47 Billion Net Income $47 Million; Net Income per Diluted Share $2.92 Adjusted Net Income $44 Million; Adjusted Net Income per Diluted Share $2.74 Adjusted EBITDA $210 Million; Adjusted EBITDA Margin 14.3% Continued Strong Liquidity of $599 Million as of December 31, 2023FRANKLIN, Tenn., Feb. 21, 2024 (GLOBE NEWSWIRE) — Kaiser Aluminum Corporation (NASDAQ:KALU), a leading producer of semi-fabricated specialty...

Continue reading

Ansys Announces Q4 and FY 2023 Financial Results

ACV by License TypeACV by License TypeRecurring ACVRecurring ACVFY 2023 ACV by IndustryFY 2023 ACV by IndustryFY 2022 ACV by IndustryFY 2022 ACV by Industry/ Q4 2023 ResultsGAAP and non-GAAP revenue of $805.1 million GAAP diluted earnings per share of $3.14 and non-GAAP diluted earnings per share of $3.94 GAAP operating profit margin of 41.4% and non-GAAP operating profit margin of 53.0% Operating cash flows of $232.7 million and unlevered operating cash flows of $242.8 million Annual contract value (ACV) of $955.2 million/ FY 2023 ResultsGAAP and non-GAAP revenue of $2,269.9 million GAAP diluted earnings per share of $5.73 and non-GAAP diluted earnings per share of $8.80 GAAP operating profit margin of 27.6% and non-GAAP operating profit margin of 42.6% Operating cash flows of $717.1 million and...

Continue reading

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 Company to Host Conference Call with Live Q&A, March 6, 2024 at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 21, 2024 – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2023, after market close on Wednesday, March 6, 2024.Title:MDxHealth Presents Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call and WebcastSpeakers: Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief Financial OfficerDate: March 6, 2024Time: 4:30pm ET/ 22:30 CETConference Call Dial-in Details:United States: 1-888-886-7786Belgium: 0800...

Continue reading

Parsons Announces Offering Of $700.0 Million Of Convertible Senior Notes Due 2029

CHANTILLY, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that it intends to offer, subject to market and other conditions, $700.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement. Parsons also expects to grant the initial purchasers in the offering an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $100.0 million aggregate principal amount of notes. The notes will be senior unsecured obligations of Parsons. The notes will accrue interest payable semiannually in arrears on March 1 and September 1 of each year, beginning on September 1, 2024. The notes will mature on March 1, 2029, unless earlier repurchased, redeemed or converted. Prior...

Continue reading

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

FREEHOLD, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) — Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell”, “our”, “us” or the “Company”), a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, today announced the closing of its initial public offering of 1,100,000 shares of its common stock at a public offering price of $6.00 per share. The gross proceeds from the offering to Chromocell, before deducting the underwriting discounts and estimated offering expenses, were approximately $6.6 million. Chromocell’s common stock is listed on the NYSE American LLC under the ticker symbol “CHRO”. A.G.P./Alliance Global Partners acted as the sole book-running manager for the public offering. The offering was made only by means of a prospectus. Copies of the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.